Article
EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer.
Cancer - 25 Feb 2009
Smouse Jason H, Cibas Edmund S, Jänne Pasi A, Joshi Victoria A, Zou Kelly H, Lindeman Neal I
Abstract excerpt
BACKGROUND: Somatic mutations in the epidermal growth factor receptor (EGFR) are present in approximately 10% of nonsmall cell lung cancers, and higher in never-smokers, women, and Asians. Small in-frame deletions in exon 19 ( approximately 45%) and L858R mutation in exon 21 ( approximately 40%) predict response to treatment with tyrosine kinase inhibitors, whereas some others herald resistance. Direct sequencing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
